Background illustration for clinical trials search

Brain Cancer Clinical Trials

Browse 315 brain cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Brain Slice Explants to Predict Drug Response in Brain Tumors

for
Central Nervous System Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 0+

Code: NCT05978557

Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: New Haven CT, Philadelphia PA, Bethesda MD, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase1, Recruiting

Clinical Orthopaedic Data Bank (Acute and Chronic)

for
Osteoarthritis, Osteosarcoma, Scoliosis, Cerebral Palsy
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 0+

Code: NCT00411060

Recruiting

Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes

for
Stroke Recurrence, Type 2 Diabetes, Prediabetes
Location: Honolulu HI
Sponsor: University of Hawaii

Sex: All

Age: 30 - 65

Code: NCT07120334

Recruiting

Individualized Neuro-Modulation Paired With Cerebellar Therapy

for
Cerebellar Ataxia, Cerebellar Diseases, Cerebellar Stroke,
Location: Baltimore MD
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07642856

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants

for
Acute Coronary Syndromes (ACS), Recent Myocardial Infarction,
Location: Miami FL
Sponsor: Shanghai CureGene Pharmaceutical Co., Ltd.

Sex: All

Age: 18 - 55

Code: NCT07619885

Phase1, Recruiting

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

for
CNS Malignancies, Medulloblastoma Recurrent, ATRT Recurrent,
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 3 - 21

Code: NCT07017816

Early_phase1, Recruiting

A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"

for
Phase 2, Radiotherapy-Induced Immune Priming, Elranatamab,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT07382739

Phase2, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase3, Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

for
Solid Tumor (Excluding CNS), Liver Cell Carcinoma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 1 - 26

Code: NCT07148050

Phase1, Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

for
Recurrent Solid Tumor, Recurrent Ewing Sarcoma,
Location: Montreal, Washington D.C. DC, Toronto, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT04901702

Phase1, Phase2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

for
Recurrent Atypical Teratoid/Rhabdoid Tumor,
Location: San Francisco CA
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 1 - 39

Code: NCT07447076

Phase2, Recruiting

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

for
Primary Central Nervous System Lymphoma (PCNSL),
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07082868

Phase1, Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06712810

Phase1, Recruiting

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

for
Aneurysm, Stroke, Vasculitis, Tumor Necrosis Factor-alpha
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT02638701

Phase1, Phase2, Recruiting

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

for
Hepatoblastoma, Hepatocellular Carcinoma, Wilms Tumor,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 21

Code: NCT06198296

Phase1, Recruiting

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

for
Movement Disorders, Parkinson Disease, Essential Tremor, Tremor,
Location: Albany NY, Tampa FL, Cleveland OH, Columbus OH,
Sponsor: Abbott Medical Devices

Sex: All

Age: 0+

Code: NCT04071847

Recruiting

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

for
Central Nervous System Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05011045

Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

for
Acquired Immunodeficiency Syndrome, BK Virus Infection,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT02479698

Phase2, Recruiting